TUESDAY, Oct. 13, 2020 (HealthDay News) — Up to 7.7 million U.S. workers lost jobs with employer-sponsored health insurance during the coronavirus pandemic, and 6.9 million of their dependents also lost coverage, a new study finds. Workers in manufacturing, retail, accommodation and food services were especially hard-hit by job losses,Continue Reading

TUESDAY, Oct. 13, 2020 (HealthDay News) — Black and Asian COVID-19 patients are more likely than white patients to have severe illness, a new British study finds. Researchers analyzed data from more than 1,800 adult COVID-19 patients admitted to King’s College Hospital in London between March 1 and June 2.Continue Reading

SATURDAY, Oct. 10, 2020 (HealthDay News) — Even as the nation’s top infectious diseases expert said Friday that the White House experienced a “superspreader” event in the Rose Garden last month, President Donald Trump announced he will hold his first public event at the White House since testing positive forContinue Reading

FRIDAY, Oct. 9, 2020 (HealthDay News) — The new coronavirus is striking the Upper Midwest with a vengeance, as Wisconsin and the Dakotas became COVID-19 hotspots and health officials scrambled for hospital beds on Thursday. After months where residents of those states downplayed the virus and rejected mask requirements, allContinue Reading

FRIDAY, Oct. 9, 2020 (HealthDay News) — The so-called love hormone, oxytocin, may be worth investigating as a treatment for COVID-19, a new study suggests. One of the most serious complications of infection with the new coronavirus is a “cytokine storm,” in which the body attacks its own tissues. ThereContinue Reading

THURSDAY, Oct. 8, 2020 (HealthDay News) — Regeneron Pharmaceuticals Inc. said Wednesday that it is seeking emergency approval from the U.S. Food and Drug Administration for an experimental antibody cocktail given to President Donald Trump shortly after he was diagnosed with COVID-19. Hours before the company made the announcement, TrumpContinue Reading

WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Following weeks of delay, the White House on Tuesday approved tough new rules for coronavirus vaccine developers that will make it unlikely that a vaccine will be approved before Election Day. The approval came only after the U.S. Food and Drug Administration publishedContinue Reading